Study reveals a new therapeutic target for aggressive type of rhabdomyosarcoma
- OPACC
- Jul 14, 2022
- 1 min read
Scientists at St. Jude Children’s Research Hospital have identified an Achilles’ heel in rhabdomyosarcoma driven by a gene fusion which revealed a promising treatment approach in the lab.
Comments